Summary: In patients with obesity and cardiovascular disease without diabetes (n=17,604) from the SELECT trial, once-weekly semaglutide 2.4 mg reduced…
Browsing: PICO
Summary: In adults with obesity without type 2 diabetes (n=725) enrolled in the phase 3 SYNCHRONIZE-1 trial across 14 countries,…
Summary: In adults with obesity or overweight without type 2 diabetes from SURMOUNT-5, tirzepatide at maximum tolerated dose for 72…
Summary: In patients with biopsy-confirmed MASH and fibrosis stage F2-F3 (n=212), once-weekly pemvidutide (1.2 or 1.8 mg), a GLP-1/glucagon dual…
Summary: In adults with overweight or obesity following 7-day vancomycin treatment, 2′-fucosyllactose (2′-FL) supplementation for 8 weeks transiently improved gut…
Summary: In patients with type 2 diabetes inadequately controlled on metformin (n=60), adding sitagliptin 100 mg/day to metformin 2000 mg/day…
Summary: In patients with type 2 diabetes inadequately controlled on metformin and glyburide (n=32), sitagliptin add-on therapy for 6 months…
Summary: In adults with type 2 diabetes (n=40), Dibifree dietary phytomix (15 g/day) as add-on therapy significantly reduced HbA1c, fasting/postprandial…
Summary: In overweight or obese adults aged 18–50 years, a standardized 60 mL daily hibiscus-inulin (HIB-INU) shot significantly reduced composite…
Summary: In adults with type 2 diabetes, Dibifree, a dietary phytomix (15 g/day) significantly improved glycemic control and reduced adiposity…